Integrated genomic and transcriptomic analysis identified KRT18 mutation and MTAP loss as key genetic alterations related to the prognosis of astrocytoma and glioblastoma. Integrated use of tumor AI ...
Hosted on MSN
AI tool accurately distinguishes between glioblastoma and primary central nervous system lymphoma
A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The ...
NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS) cancers today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback